Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YALA
2026
Yalla Group
YALA
$841M
| $6.14M | ﹤0.01% |
817,404
+717,084
| +715% | +$5.53M |
|
2027
MarketAxess Holdings
MKTX
$5.71B
| $6.13M | ﹤0.01% |
35,172
-104,908
| -75% | -$20.5M |
|
2028
Alarm.com
ALRM
$2.76B
| $6.12M | ﹤0.01% |
115,287
-22,248
| -16% | -$1.24M |
|
|
WAY
2029
Waystar Holding Corp
WAY
$4.56B
| $6.11M | ﹤0.01% |
161,177
-19,163
| -11% | -$710K |
|
2030
Innoviva
INVA
$1.54B
| $6.11M | ﹤0.01% |
334,777
+196,096
| +141% | +$3.82M |
|
2031
Life Time Group Holdings
LTH
$10B
| $6.1M | ﹤0.01% |
221,178
-230,288
| -51% | -$6.57M |
|
|
APLS
2032
DELISTED
Apellis Pharmaceuticals
APLS
| $6.1M | ﹤0.01% |
269,527
-4,385
| -2% | -$102K |
|
2033
CALL
Airbnb
ABNB
$89B
| $6.1M | ﹤0.01% |
+50,200
| New | +$6.49M |
|
2034
Virtu Financial
VIRT
$5.03B
| $6.08M | ﹤0.01% |
171,390
+58,327
| +52% | +$2.4M |
|
2035
Dyne Therapeutics
DYN
$4.85B
| $6.08M | ﹤0.01% |
480,701
+160,211
| +50% | +$1.83M |
|
2036
Repay Holdings
RPAY
$343M
| $6.05M | ﹤0.01% |
1,157,337
+36,224
| +3% | +$194K |
|
2037
Insight Enterprises
NSIT
$4.15B
| $6.04M | ﹤0.01% |
53,298
-47,743
| -47% | -$6.21M |
|
2038
Xerox
XRX
$424M
| $6.04M | ﹤0.01% |
1,607,378
-70,251
| -4% | -$310K |
|
2039
CALL
Dropbox
DBX
$8.05B
| $6.03M | ﹤0.01% |
+199,600
| New | +$5.71M |
|
2040
CALL
Ultragenyx Pharmaceutical
RARE
$2.54B
| $6.02M | ﹤0.01% |
200,000
-191,600
| -49% | -$5.75M |
|
2041
CALL
IonQ
IONQ
$15.6B
| $6M | ﹤0.01% |
97,500
-2,500
| -3% | -$118K |
|
|
UCB
2042
United Community Banks
UCB
$4.33B
| $5.99M | ﹤0.01% |
191,068
-84,865
| -31% | -$2.68M |
|
2043
Kohl's
KSS
$2.28B
| $5.99M | ﹤0.01% |
389,598
-632,883
| -62% | -$8.44M |
|
2044
CONMED
CNMD
$1.51B
| $5.96M | ﹤0.01% |
126,735
-27,783
| -18% | -$1.44M |
|
2045
AppFolio
APPF
$7.07B
| $5.96M | ﹤0.01% |
21,614
+10,946
| +103% | +$2.96M |
|
2046
PUT
Carrier Global
CARR
$54.1B
| $5.96M | ﹤0.01% |
99,800
-1,482,700
| -94% | -$101M |
|
2047
Blackbaud
BLKB
$2.07B
| $5.95M | ﹤0.01% |
92,448
+9,551
| +12% | +$626K |
|
2048
BioCryst Pharmaceuticals
BCRX
$2.29B
| $5.94M | ﹤0.01% |
782,232
-21,880
| -3% | -$182K |
|
2049
Rogers Communications
RCI
$18.3B
| $5.92M | ﹤0.01% |
171,833
+161,718
| +1,599% | +$5.57M |
|
2050
AAR Corp
AIR
$5.96B
| $5.91M | ﹤0.01% |
65,934
-17,997
| -21% | -$1.37M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.